Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- What is the Stock Market's Achilles Heel?
- 3 Dividend Stocks at Reasonable Prices
- RTI: Are You Doing the Elon Musk Trade?
- Buy These ETFs to Profit from "Sector Rotation"
- Oil & Gas Industry Stock Outlook - May 2013
- Uncharted Territory
- 4 Ways to Short Oil with ETFs
- Options Strategies & the Zacks Rank
- This Week's Growth & Income Stocks
- AWS 5/17: The Fed: The Only Game in Town
- PFP 5/17: The ONLY Investment Story
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/17/2013
| Company Name | Symbol | %Change |
|---|---|---|
| VIASAT INC | VSAT | 19.35% |
| OLD SECOND B | OSBC | 5.76% |
| GAMCO INVEST | GBL | 4.61% |
| CORNING INC | GLW | 4.47% |
| SYNCHRONOSS | SNCR | 4.23% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Jan 29, 2013, we retained Intuitive Surgical ( ISRG - Analyst Report ) , the pioneer in minimally invasive robotic surgery, at Outperform following its strong results for the fourth quarter 2012. The company has delivered positive earnings and sales surprises in each of the last four quarters.
Why the Retention?
Intuitive Surgical announced fourth quarter 2012 results on Jan 22. Fourth quarter earnings per share came in at $4.25 well above the Zacks Consensus Estimate of $4.03. Intuitive Surgical reported revenues of $609.3 million for the fourth quarter, up 22.6% year over year and surpassing the Zacks Consensus Estimate of $584 million.
Over the last 30 days, the Zacks Consensus Estimate for 2013 has moved up by 10 cents to $17.60. Moreover, the Zacks Consensus Estimate for 2014 has risen 6 cents to $20.48 during the same period.
The Intuitive Surgical growth story remains compelling. The company issued favorable guidance for 2013. Intuitive Surgical expects procedure count to increase by 20% to 23% for 2013 propelled by general surgery and gynecology procedures in the domestic market and overseas prostatectomy procedures. The company expects revenues to grow in the range of 16% to 19% for 2013 with higher sales in the fourth quarter than in the first quarter. Operating income is expected in a band of 38% to 39% of sales for 2013.
Intuitive Surgical’s recurring revenue stream continues to be robust and provides a shield against cyclicality of revenues, arising from the sale of discretionary capital equipment to hospitals. Recurring revenues increased 27% year over year in the fourth quarter 2012 and constituted 57% of revenues.
However, we believe that until the global economy recovers, the stock may come under pressure as investors ponder whether lingering macro economic uncertainty will weaken hospitals’ commitment to buy high-cost robotic systems. In the meantime, the installed base of the company continues to grow as hospitals feel compelled to upgrade their technology. Intuitive competes with Accuray Incorporated ( ARAY - Analyst Report ) in certain niches.
Other Stocks to Consider
Other stocks which are expected to do well include Cantel Medical Corp. ( CMN - Snapshot Report ) and Cyberonics Inc. ( CYBX - Analyst Report ) . Both are rated at Zacks Rank #1 (Strong Buy).
Read the full Analyst Report on ISRG
Read the full Analyst Report on ARAY
Read the full Analyst Report on CYBX
Read the full Snapshot Report on CMN